191 related articles for article (PubMed ID: 26922203)
1. Rheumatoid arthritis and associated large granular lymphocytic leukemia--successful treatment with rituximab.
Raposo A; Cerqueira M; Costa J; Sousa Neves J; Teixeira F; Afonso C
Acta Reumatol Port; 2015; 40(4):384-7. PubMed ID: 26922203
[TBL] [Abstract][Full Text] [Related]
2. T-Cell Large Granular Lymphocyte Leukemia in a Patient With Rheumatoid Arthritis.
Naji Rad S; Rafiee B; Raju G; Solhjoo M; Anand P
J Investig Med High Impact Case Rep; 2020; 8():2324709620941303. PubMed ID: 32646239
[TBL] [Abstract][Full Text] [Related]
3. T cell large granular lymphocyte leukemia associated with rheumatoid arthritis and neutropenia.
Shah A; Diehl LF; St Clair EW
Clin Immunol; 2009 Aug; 132(2):145-52. PubMed ID: 19394280
[TBL] [Abstract][Full Text] [Related]
4. Treatment of pseudo Felty's syndrome: Is there a place for rituximab?
Verhoeven F; Guillot X; Prati C; Wendling D
Joint Bone Spine; 2015 May; 82(3):196-9. PubMed ID: 25623522
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiologic mechanisms and management of neutropenia associated with large granular lymphocytic leukemia.
Pontikoglou C; Kalpadakis C; Papadaki HA
Expert Rev Hematol; 2011 Jun; 4(3):317-28. PubMed ID: 21668396
[TBL] [Abstract][Full Text] [Related]
6. How I treat LGL leukemia.
Lamy T; Loughran TP
Blood; 2011 Mar; 117(10):2764-74. PubMed ID: 21190991
[TBL] [Abstract][Full Text] [Related]
7. The complex relationship between large granular lymphocyte leukemia and rheumatic disease.
Marchand T; Lamy T
Expert Rev Clin Immunol; 2024 Mar; 20(3):291-303. PubMed ID: 38105745
[TBL] [Abstract][Full Text] [Related]
8. Rituximab for rheumatoid arthritis-associated large granular lymphocytic leukemia, a retrospective case series.
Lobbes H; Dervout C; Toussirot E; Felten R; Sibilia J; Wendling D; Gombert B; Ruivard M; Grobost V; Saraux A; Cornec D; Verhoeven F; Soubrier M
Semin Arthritis Rheum; 2020 Oct; 50(5):1109-1113. PubMed ID: 32920324
[TBL] [Abstract][Full Text] [Related]
9. Rates of serious infections and malignancies among patients with rheumatoid arthritis receiving either tumor necrosis factor inhibitor or rituximab therapy.
Aaltonen KJ; Joensuu JT; Virkki L; Sokka T; Aronen P; Relas H; Valleala H; Rantalaiho V; Pirilä L; Puolakka K; Uusitalo T; Blom M; Konttinen YT; Nordström D
J Rheumatol; 2015 Mar; 42(3):372-8. PubMed ID: 25593230
[TBL] [Abstract][Full Text] [Related]
10. VARIAR Study: Assessment of short-term efficacy and safety of rituximab compared to an tumor necrosis factor alpha antagonists as second-line drug therapy in patients with rheumatoid arthritis refractory to a first tumor necrosis factor alpha antagonist.
Torrente-Segarra V; Acosta Pereira A; Morla R; Ruiz JM; Clavaguera T; Figuls R; Corominas H; Geli C; Roselló R; de Agustín JJ; Alegre C; Pérez C; García A; Rodríguez de la Serna A
Reumatol Clin; 2016; 12(6):319-322. PubMed ID: 26831256
[TBL] [Abstract][Full Text] [Related]
11. Drivers of costly treatment strategies in rheumatoid arthritis.
Huizinga TW; Gröndal G
Lancet; 2016 Jul; 388(10041):213-4. PubMed ID: 27197691
[No Abstract] [Full Text] [Related]
12. Use of etanercept to treat rheumatoid arthritis in an HIV-positive patient: a case-based review.
Liang SJ; Zheng QY; Yang YL; Yang Y; Liu CY
Rheumatol Int; 2017 Jul; 37(7):1207-1212. PubMed ID: 28255643
[TBL] [Abstract][Full Text] [Related]
13. T cell large granular lymphocytic leukemia in association with Sjögren's syndrome.
Franco G; Palazzolo R; Liardo E; Tripodo C; Mancuso S
Acta Haematol; 2010; 124(1):5-8. PubMed ID: 20501987
[TBL] [Abstract][Full Text] [Related]
14. Complete disappearance of pulmonary rheumatoid nodules after long term rituximab treatment: case report.
Frade-Sosa B; Azuaga AB; Ruiz-Esquide V; Gómez-Puerta JA; Sanmarti R
Rheumatol Int; 2023 Mar; 43(3):533-536. PubMed ID: 36318308
[TBL] [Abstract][Full Text] [Related]
15. Sustained response to rituximab in a TNFi-induced ANCA-vasculitis developed in a patient with rheumatoid arthritis.
Florez H; Morlà R; Castellanos-Moreira R; Sanmartí R
Semin Arthritis Rheum; 2018 Feb; 47(4):e15-e16. PubMed ID: 29150206
[No Abstract] [Full Text] [Related]
16. Long-term remission of T-cell large granular lymphocyte leukemia associated with rheumatoid arthritis after rituximab therapy.
Cornec D; Devauchelle-Pensec V; Jousse-Joulin S; Marhadour T; Ugo V; Berthou C; Douet-Guilbert N; Saraux A
Blood; 2013 Aug; 122(9):1583-6. PubMed ID: 23869084
[TBL] [Abstract][Full Text] [Related]
17. [Rituximab in patients with rheumatoid arthritis: systematic review].
Brodszky V; Czirják L; Géher P; Hodinka L; Kárpáti K; Péntek M; Poór G; Szekanecz Z; Gulácsi L
Orv Hetil; 2007 Oct; 148(40):1883-93. PubMed ID: 17905683
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid arthritis and ocular myasthenia gravis: Effectiveness of rituximab in the management of these two diseases.
Novella-Navarro M; Salvatierra-Ossorio J; Muñoz-Gómez MDM; Pavo-Blanco M
Reumatol Clin (Engl Ed); 2018; 14(3):179-180. PubMed ID: 28624374
[No Abstract] [Full Text] [Related]
19. Large granular lymphocyte leukemia as a complication of rheumatoid arthritis.
Lois Iglesias A; Sifuentes Giraldo WA; Bachiller Corral J; Saiz González A; Brito Brito E; Zea Mendoza A
Reumatol Clin; 2012; 8(6):365-7. PubMed ID: 22483660
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Rituximab for the Treatment of Rheumatoid Arthritis in Patients with Prior Exposure to Anti-TNF: Results from the CORRONA Registry.
Harrold LR; Reed GW; Shewade A; Magner R; Saunders KC; John A; Kremer JM; Greenberg JD
J Rheumatol; 2015 Jul; 42(7):1090-8. PubMed ID: 25934829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
